KOKO Medical Announces Headquarters Relocation to Hankin Group’s Eagleview in Exton, PA
The medical equipment manufacturing company leases more than 19,000 square feet at 770 Pennsylvania Drive
EXTON, PA (September 10, 2024) – Hankin Group, a vertically integrated real estate company, has announced that KOKO Medical Inc., a medical device and women’s health company, has moved its corporate headquarters to 770 Pennsylvania Drive at Eagleview in Exton, PA. The 19,859 square foot space is an expansion for the Malvern-based startup, which is committed to saving the lives of mothers through innovative medical products.
The relocation and expansion are a critical step in KOKO Medical’s business trajectory, as the startup prepares to transition from development into commercial manufacturing. The organization is an early-stage catheter-based technology to treat postpartum hemorrhage, which is experienced by more than 10% of women during childbirth and can lead to death and other severe complications.
“We are committed to bringing the highest quality, safest product to market in order to save the lives of countless mothers, and we needed a purpose built, medical manufacturing facility that could be tailored to meet the needs of our business,” said Jason Keiser, co-founder and vice president of operations, KOKO Medical Inc. “Between the state-of-the-art facility, on-site amenities, and superior property management, Eagleview was an ideal option for our next phase.”
“We are thrilled to officially welcome KOKO Medical into their brand-new headquarters at Eagleview, a burgeoning hub for the life sciences sector,” said Bob Hankin, CEO, Hankin Group. “We are confident Eagleview will be an excellent new home for KOKO Medical during an exciting chapter of innovation and growth for the company.”
770 Pennsylvania Drive is a fully leased 63,000 square foot flex building designed for office, research & development, pharmaceutical, light manufacturing and assembly, and warehouse uses. The addition of KOKO Medical signals the continued growth of the life sciences industry in the Greater Philadelphia region.
Hankin Group also recently announced the addition of Frontage Laboratories, a full spectrum CDMO, and Fruh Packaging, a Swiss pharmaceutical packaging company, at 240 Sierra Drive at Eagleview. In addition to 240 Sierra Drive, Hankin Group has delivered one million square feet of life sciences, research, and development space in Eagleview, with tenants including West Pharmaceutical Services, Takeda Pharmaceuticals, Castle Biosciences, DSM, Immunome, and more.
Eagleview is an award-winning, 800-acre mixed-use community located in Chester County, PA. The master planned community boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
KOKO Medical was represented by Mitch Reading of Tactix Real Estate Advisors. Hankin Group was represented internally by Sam Sherrill.
For additional information on Eagleview, visit www.hankingroup.com/eagleview.